FSKR yields 10.20% · JNJ yields 2.13%● Live data
📍 FSKR pulled ahead of the other in Year 1
Combined, FSKR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FSKR + JNJ for your $10,000?
FS KKR Capital Corp. II, formerly known as FS Investment Corp II, is a business development company specializing in investments in floating rate, senior secured loans-first lien and second line, senior secured bonds, subordinated debt, collateralized securities, corporate bonds, debt securities, equity such as warrants or options in middle market private companies. The fund does not intend to invest to any significant degree in start-up companies, turnaround situations or companies with speculative business plans. It seeks to invest in various sectors such as consumer services, energy, capital goods, software and services, telecommunication services, consumer durables and apparel, diversified financials, materials, automobiles and components, commercial and professional services, media, technology hardware and equipment, health care equipment and services, insurance, retailing, transportation, pharmaceuticals, biotechnology, and life sciences, food and staples retailing, food, beverage, and tobacco, household and personal products, real estate, and utilities. The fund seeks to invest in private companies based in the United States. It also invests in non-U.S. securities, which may include securities denominated in U.S. dollars or in non-U.S. currencies, to the extent permitted by the 1940 Act. The fund purchase interests in loans through secondary market transactions in the ?over-the-counter? market for institutional loans or directly from our target companies. It also purchase minority interests in the form of common or preferred equity in target companies, either in conjunction with one of its debt investments or through a co-investment with a financial sponsor, such as an institutional investor or private equity firm. It may have board representation or board observation rights in its portfolio companies.
Full FSKR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.